| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | -$7.08M | -25K | -0.42% | $283.11 | 5.89M | Nov 14, 2023 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | -$9.35M | -33K | -0.56% | $283.42 | 5.86M | Nov 15, 2023 | Direct | F1, F3 |
| transaction | MEDP | Common Stock | Sale | -$4.79M | -17K | -0.29% | $281.61 | 5.84M | Nov 16, 2023 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $281.20 to $286.67. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $282.00 to $286.53. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F4 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $280.10 to $284.11. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |